Mandate

Vinge has assisted Cavotec in connection with listing and admission to trading on NASDAQ OMX Stockholm

October 21, 2011

Cavotec is a global engineering group, supplying innovative and environmentally friendly systems to the ports and maritime, airports, mining and tunnelling and general industry sectors.

Cavotec MSL Holdings Ltd has been listed on the New Zealand Exchange since 2007. In April 2011, the shareholders of Cavotec MSL Holdings Ltd voted in favour of a so called Scheme of Arrangement in order to move the domicile of Cavotec to Switzerland with a new parent company, Cavotec SA. The Board of Directors of Cavotec SA has subsequent to the decision applied for and received approval for listing of Cavotec SA’s shares on NASDAQ OMX Stockholm.

The objective of the listing on NASDAQ OMX Stockholm is to locate the company closer to its main markets and to access a stronger and broader investor base. The last day of trading in the Cavotec MSL Holding Ltd share on the New Zeeland Exchange was 26 September 2011 and the first day of trading in the Cavotec SA share on NASDAQ OMX Stockholm was 19 October 2011.

Vinge’s team has primarily consisted of Göran Nyström, Jesper Schönbeck and Joakim Hagberg and, as regards tax law, Maria Doeser.

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025